DL-HOMOCYSTINE (3,3,3,3,4,4,4,4-D8) is a deuterium-labeled, stereochemically specified as the DL (racemic) form, disulfide-linked amino acid derivative consisting of two homocysteine units connected by a cystine-type S-S bond. The molecule bears two carboxyl groups and two amino groups associated with the homocysteine residues, while the side chains are linked through the oxidized disulfide functionality; the eight deuterium atoms (3,3,3,3,4,4,4,4-D8) are incorporated into the labeled carbon framework of the side chains. In biochemical and analytical research, this isotopically labeled homocystine analogue is used for isotopic tracing and quantitative mass spectrometric or NMR method development, and it serves as a chemically defined precursor for preparing further homocysteine- or cystine-related amino acid and peptide derivatives where isotopic labeling is required.
CAT No: L-Iso-0320
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.